| |
| |
|
| Insider
Information: |
Kieffer Tara Lynn |
| Relationship: |
Chief Product Strategy... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,607 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$537,071 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,607 |
|
|
| Total
Value |
$537,071 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Chief Product Strategy... |
2024-02-12 |
39,607 |
2022-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Chief Product Strategy Officer |
• – – |
2024-02-12 |
4 |
D |
$12.41 |
$12,075 |
D/D |
(973) |
39,607 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Product Strategy Officer |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,320 |
40,580 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Prod. Strat. & Dev |
• – – |
2023-12-05 |
4 |
S |
$9.63 |
$20,464 |
D/D |
(2,125) |
37,260 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Prod. Strat. & Dev |
• – – |
2023-12-01 |
4 |
D |
$9.49 |
$7,146 |
D/D |
(753) |
39,385 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2023-02-13 |
4 |
D |
$52.77 |
$354,878 |
D/D |
(6,725) |
40,138 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,997 |
46,863 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2022-12-01 |
4 |
D |
$44.33 |
$22,076 |
D/D |
(498) |
25,866 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2022-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
26,364 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2022-02-14 |
4 |
D |
$62.49 |
$34,494 |
D/D |
(552) |
7,864 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, New Product Dev. |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,616 |
8,416 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
